Section Menu

HeartKids funds ground-breaking new research

HeartKids funds ground-breaking new research in the fight against congenital heart disease

HeartKids Grants-in-Aid Program will provide $273,000 to support a range of new Australian research projects into congenital and acquired childhood heart disease in 2018.

The seven grant recipients selected this year will undertake research into the causes, treatment and management of congenital/childhood heart disease, for which there is no known cure, helping to better understand the mysteries behind it.

The official announcement was made at HeartKids Research Showcase and 2018 Conquering Childhood Heart Disease Research Grants Presentation in Melbourne on Saturday 28 April.

This event also highlights the tremendous impact of recently funded projects which are already making a practical difference in the lives of infants, children, young people and adults impacted by congenital/childhood heart disease.

The HeartKids Grants-in-Aid program is unique as it provides funding for smaller projects (minimum $20,000 and maximum of $50,000 incl GST) with a shorter duration of 12 months maximum.

The Grants-in-Aid are intended to support and grow research capacity specifically directed to congenital/childhood heart disease and enable pilot studies which may lead to larger, longer-term research projects.

Since 2011, HeartKids has invested more than $3.5 million in research to deliver timely outcomes which make a real difference to people impacted by congenital/childhood heart disease.

HeartKids is the only not-for-profit organisation in Australia which funds research into congenital/childhood heart disease, and has always relied on support from its sponsors and donors.

Mark Brooke, CEO, HeartKids Australia, said: “The Grants-in-Aid Program acts as a kind of seed funding for pilot studies and initial research and assessment. These studies can go on to become much larger, long term investigations.

“The 2018 Grants-in-Aid projects cover diverse areas including genetics, the impact of congenital/childhood heart disease and surgery on children’s learning, behaviour and development,
survival rates, cord blood cell therapy, and resources for teaching paediatric cardiology and training surgeons.

“Research is vital. Every day, 8 babies are born with congenital heart disease and every week 4 will die. While surgery is not a cure, 50 per cent of those born with congenital heart disease will require an operation before their first birthday.

There are currently more than 32,000 adult Australians who have lived with a heart defect since childhood.

The potential complications and future treatment needs for many of these adults are still not fully understood.

“Congenital Heart Disease is the leading cause of death of Australian children under the age of one and our organisation is dedicated to supporting research into its causes, treatment and management.”